The main task of the NeuroPharm Steering Group is to assist and provide consultancy to the Center Director, for example in relation to major changes in the projects, meeting arrangements, and involvement of external experts. The members of NeuroPharm's steering group are:
|
|
Center Director: Prof. Gitte Moos Knudsen Neurobiology Research Unit, Rigshospitalet and University of Copenhagen Prof. Knudsen is a translational neurobiologist and clinical neurologist and is internationally renowned for her seminal contributions to the basic, preclinical and clinical investigations of neurobiological mechanisms underlying brain disorders such as affective and neurodegenerative disorders. She has extensive scientific leadership experience from 10 years of independent research leadership at the Neuroscience Center at Rigshospitalet, and as a professor of Clinical Neurobiology at the University of Copenhagen. |
|
|
Prof. Bruce Rosen Athinoula A. Martinos Center for Biomedical Imaging at Massachusetts General Hospital, Boston, USA Prof. Rosen is a highly recognized MR-scientist and a world-leading expert in functional neuroimaging. He is Professor of Radiology at the Harvard Medical School and Professor of Health Science and Technology at the Harvard-MIT Division of Health Sciences and Technology. |
|
|
Prof. David Nutt Imperial College London, UK Prof. Nutt is a clinical psychiatrist and neuropharmacologist. He is currently the Edmond J Safra Professor of Neuropsychopharmacology and director of the Neuropsychopharmacology Unit in the Division of Brain Sciences at Imperial College London. |
|
|
Associate Prof. Esben Budtz-Jørgensen Department of Biostatistics, University of Copenhagen Dr. Budtz-Jørgensen is a biostatistician with a considerable experience in statistical analysis of complex multivariate data. One of his main research topics has been how to use structural equation models in the field of environmental epidemiology, and he has also done research on methods for model selection and modelling of genetic and imaging data. |
|
|
Prof. Jens D. Mikkelsen Neurobiology Research Unit, Rigshospitalet and University of Copenhagen Prof. Mikkelsen is a translational neuropharmacologist with more than 10 years of experience from drug discovery in the pharmaceutical industry. |
|
|
Eugenii (Ilan) Rabiner Imanova Ltd., London, UK Dr. Rabiner is Head of Imaging Applications and CMO of Imanova Ltd., which is a private British-based company that specialises in cutting edge imaging support for Pharma and academia. Dr. Rabiner is a psychiatrist and psychopharmacologist with almost 20 years experience in the development of novel molecular imaging methods and their application to experimental medicine and novel drug development. |
|
|
Birgitte Søgaard H. Lundbeck A/S, Valby, DK Dr. Søgaard is Divisional Director for Clinical and Quantitative Pharmacology and Head of department in Clinical Pharmacology including Clinical Pharmacology Operations at H. Lundbeck A/S. She has worked with clinical pharmacology for 25 years with focus on the establishment of biological models to be able to quantify and describe biological responses to support drug development. |
|
|
Prof. Sven Frøkjær Faculty of Health and Medical Sciences, University of Copenhagen Prof. Frøkjær is a drug formulation scientist with significant experience from both academia and the pharmaceutical industry. |
|
|
Center Manager: Peter Steen Jensen Neurobiology Research Unit, Rigshospitalet
|
